Element Biosciences

Executive Summary

Element Biosciences, founded in 2017 and headquartered in San Diego, is a private biotechnology company developing affordable benchtop sequencing and multiomics platforms. Its flagship AVITI™ system aims to democratize genomic data by delivering high-quality sequencing at a lower cost, enabling broader access for researchers. The company targets the genetics and genomics sector, focusing on scaling biological discovery without traditional premium pricing. With a mission to 'open the world of biology to new possibilities,' Element Biosciences positions itself as a disruptive player in the next-generation sequencing market, competing with established incumbents by emphasizing cost efficiency and accessibility.

Upcoming Catalysts (preview)

• Q2 2026Commercial launch of enhanced AVITI platform features or new consumables80% success
• H2 2026Strategic partnership with major research institution or pharmaceutical company60% success
• Q4 2026Series D or later funding round to scale manufacturing and commercialization70% success